Safe ScanPrice

(SN76)

Safe Scan is a decentralized AI marketplace dedicated to improving cancer diagnostics, specifically focusing on melanoma detection. It utilizes the Bittensor network to incentivize the development of high-accuracy screening algorithms. Through its open-source SELFSCAN application, the project aims to provide free skin cancer screening tools to smartphone users worldwide, leveraging decentralized compute to democratize healthcare access.

The project utilizes a three-tier system of participants. Miners provide computational resources to run AI diagnostic models. Validators assess the performance of these models, ensuring the highest accuracy through consensus-based ranking. Users benefit from free diagnostic tools or can choose to contribute annotated medical data to improve the AI's training, receiving rewards for their contributions to the network's knowledge base.

SN76 is the native alpha token for Subnet 76, facilitating various ecosystem functions. It is used for staking, allowing participants to support the subnet's growth. It also serves as a governance tool, giving holders the ability to influence the direction of the project. Furthermore, the token acts as an incentive for contributors, including researchers, miners, and data providers who help advance the AI's diagnostic capabilities.

Safe Scan was founded by Mateusz Woźniak and Wojciech Jurkowlaniec. Their vision is centered on Decentralized Science (DeSci), focusing on creating real-world utility for AI in the healthcare sector. By moving beyond speculative use cases, the founders aim to use blockchain technology to solve tangible medical problems, earning praise for their commitment to high-impact, open-source scientific development.

SN76 can be traded on exchange platforms like LBank, which provides a secure environment for accessing Bittensor-based tokens. To store tokens, users can add SN76 as a custom token to their compatible digital wallets by importing the official smart contract address found on the project's website or official network explorers. It is important to verify all contract information through official channels to ensure the security of your assets.

The project’s roadmap focuses on scaling its impact through regulatory milestones, including pursuing medical certifications to elevate the tool from a research platform to a certified diagnostic application. Future plans involve expanding the AI's diagnostic range to include other conditions, such as breast or lung cancer, and launching the SELFSCAN app on major mobile application stores to reach millions of users globally.